Northwestern University Human Resources
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer
- Conditions
- Kidney Cancer
- Interventions
- Biological: aldesleukinBiological: denileukin diftitox
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-05-22
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 20
- Registration Number
- NCT00278369
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
- Conditions
- Chronic Inflammatory Demyelinating Polyneuropathy
- Interventions
- Biological: hematopoietic stem cell transplantation
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 80
- Registration Number
- NCT00278629
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Stem Cell Injection for Peripheral Vascular Disease
- Conditions
- Peripheral Vascular Disease
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 10
- Registration Number
- NCT00278603
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Hematopoietic Stem Cell Support in Vasculitis
- Conditions
- Vasculitis
- Interventions
- Biological: Autologous Stem Cell TransplantBiological: Allogeneic Stem Cell Transplant
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 7
- Registration Number
- NCT00278512
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Biological: Allogeneic Stem Cell Transplantation
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00278590
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Dietary Supplementation With Soy Isoflavones in Asthma
- Conditions
- Asthma
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2011-02-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 13
- Registration Number
- NCT00277446
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Improving Communication With Patients With Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 30
- Registration Number
- NCT00276822
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
- Conditions
- Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
- Interventions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 31
- Registration Number
- NCT00276783
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
- Conditions
- Melanoma (Skin)Kidney Cancer
- Interventions
- Biological: High-dose interleukin-2Dietary Supplement: genistein
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 15
- Registration Number
- NCT00276835
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2020-02-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 50
- Registration Number
- NCT00275067
- Locations
- 🇺🇸
Hematology-Oncology Associates of Illinois, Chicago, Illinois, United States
🇺🇸Edward Cancer Center, Naperville, Illinois, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States